United States· US:63539-044_0c63e82e-8c0d-4177-8748-20c2ece2b5e6

INLYTA

A axitinib product containing axitinib, registered in United States by U.S. Pharmaceuticals. The same ATC class is registered in 14 of our 19 countries.

ATC L01EK01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedINLYTAATCL01EK01REGISTER NO.US:63539-044_0c63e82e…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Axitinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EK01 (axitinib), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Axitinib · ATC L01EK01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of axitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Axitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$89.71
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AXITINIB
Manufacturer
U.S. Pharmaceuticals
Country
United States (US)
ATC code
L01EK01
ATC class
Axitinib
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    63539-044-02
  • ndc11
    6353904402
    30 TABLET, FILM COATED in 1 BOTTLE (63539-044-02)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

205 interactions on record for axitinib.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Axitinib · interactions on record

205 records

  • 64 severe
  • 117 moderate
  • 24 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • BosentanC02KX01severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Axitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All axitinib products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Axitinib, Axitinib Sandoz
  • Belgium · Axitinib Eg, Axitinib Eg (Eurogenerics)
  • Bulgaria · Axitinib Sandoz, Акситиниб Тева
  • Cyprus · Axitinib Sandoz, Axitinib Stada
  • Germany · Axitinib Al, Axitinib Hexal
  • Denmark · Axitinib Stada, Axitinib Teva
  • Estonia · Axitinib Sandoz, Axitinib Stada
  • Spain · Axitinib Stada, Axitinib Teva
  • Finland · Axitinib Avansor, Axitinib Sandoz
  • France · Axitiinib Eg, Axitinib Biogaran
  • United Kingdom (Northern Ireland) · Axitinib Genus Pharmaceuticals, Axitinib Teva Uk
  • Greece · Axitinib Faran, Axitinib Sandoz
  • Croatia · Aksitinib Alpha-Medical, Aksitinib Teva
  • Hungary · Axitinib Onkogen, Axitinib Sandoz
  • Iceland · Axitinib Accord, Axitinib Stada
  • Italy · Axitinib Eg, Axitinib Sandoz
  • Liechtenstein · Axitinib Accord, Inlyta
  • Lithuania · Axitinib Sandoz, Axitinib Stada
  • Luxembourg · Axitinib Eg, Axitinib Synthon
  • Latvia · Axitinib Sandoz, Axitinib Stada
  • Malta · Axitinib Synthon
  • Netherlands · Axitinib Sandoz, Axitinib Stada
  • Norway · Axitinib Accord, Axitinib Sandoz
  • Portugal · Axitinib Teva
  • Romania · Axitinib Stada
  • Sweden · Axitinib Avansor, Axitinib Sandoz
  • Slovenia · Aksitinib Sandoz, Aksitinib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3c1dd5b-4193-4aaf-935f-f391c80dd052
GET /v1/drugs/b3c1dd5b-4193-4aaf-935f-f391c80dd052?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "AXITINIB",
  "productndc": "63539-044",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA202324",
  "marketing_category": "NDA"
}

See everything about axitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.